Paula Goodman Fraenkel, M.D.
| Title | Assistant Professor of Medicine |
|---|
| Institution | Beth Israel Deaconess Medical Center |
|---|
| Department | Medicine |
|---|
| Address | Beth Israel Deaconess Med Ctr Hematology/Oncology, SLD 423B 330 Brookline Ave Boston MA 02215
|
|---|
| Phone | 617/667-4815 |
|---|
|
|
|
Overview Anemia is a common medical problem, particularly in the elderly, which is associated with cognitive impairment, frailty, and increased mortality. Anemia is frequently caused by impaired intestinal iron absorption or by inadequate release of iron from macrophage iron stores. On the other hand, iron overload affects numerous individuals with hereditary hemochromatosis, hemoglobin disorders, and chronic transfusions. The focus of my research is to improve our understanding of the genetic pathways that affect blood development and iron homeostasis and thus cause either anemia and iron overload disorders using zebrafish, mouse, and tissue culture models. To that end, we are identifying small molecules that increase expression of the iron regulatory hormone hepcidin that may lead to new therapies for iron overload disorders. Ongoing collaborations include the following: (1) inflammatory bowel disease models Dr. Efi Kokkotou (Division of Gastroenterology, BIDMC), (2) the effect of vitamin D deficiency on erythropoiesis with Dr. Gary Vanasse (Division of Hematology/Oncology, BWH), and (3) functional toxicology with Dr. Chris Vulpe (UC Berkeley). In addition to research, I teach and precept Harvard undergraduate students, medical students, residents, and fellows, and serve as an Attending Physician on the Hematology/Oncology Consult Service, the Hematologic Malignancy/Bone Marrow Transplant Service, and the Hematology Clinic at Beth Israel Deaconess Medical Center.
Mentoring Available: 09/10/12, Expires: 09/09/13 Iron overload, as a result of frequent blood transfusion and increased nutritional iron uptake, often causes death and disability in individuals with hereditary forms of anemia. The current therapies are inconvenient and only partially effective. Using high throughput screening, our laboratory is identifying new candidate drugs to prevent iron overload. We are looking for a student who will work with us to test the effects of small molecules on preventing iron overload in mouse models of human diseases. Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
Faculty can login to make corrections and additions.
-
Gibert Y, Lattanzi VJ, Zhen AW, Vedder L, Brunet F, Faasse SA, Babitt JL, Lin HY, Hammerschmidt M, Fraenkel PG. BMP signaling modulates hepcidin expression in zebrafish embryos independent of hemojuvelin. PLoS One. 2011; 6(1):e14553.
-
Fraenkel PG, Gibert Y, Holzheimer JL, Lattanzi VJ, Burnett SF, Dooley KA, Wingert RA, Zon LI. Transferrin-a modulates hepcidin expression in zebrafish embryos. Blood. 2009 Mar 19; 113(12):2843-50.
-
Dooley KA, Fraenkel PG, Langer NB, Schmid B, Davidson AJ, Weber G, Chiang K, Foott H, Dwyer C, Wingert RA, Zhou Y, Paw BH, Zon LI. montalcino, A zebrafish model for variegate porphyria. Exp Hematol. 2008 Sep; 36(9):1132-42.
-
Paffett-Lugassy N, Hsia N, Fraenkel PG, Paw B, Leshinsky I, Barut B, Bahary N, Caro J, Handin R, Zon LI. Functional conservation of erythropoietin signaling in zebrafish. Blood. 2007 Oct 1; 110(7):2718-26.
-
Wingert RA, Galloway JL, Barut B, Foott H, Fraenkel P, Axe JL, Weber GJ, Dooley K, Davidson AJ, Schmid B, Schmidt B, Paw BH, Shaw GC, Kingsley P, Palis J, Schubert H, Chen O, Kaplan J, Zon LI. Deficiency of glutaredoxin 5 reveals Fe-S clusters are required for vertebrate haem synthesis. Nature. 2005 Aug 18; 436(7053):1035-39.
-
Fraenkel PG, Traver D, Donovan A, Zahrieh D, Zon LI. Ferroportin1 is required for normal iron cycling in zebrafish. J Clin Invest. 2005 Jun; 115(6):1532-41.
-
Wingert RA, Brownlie A, Galloway JL, Dooley K, Fraenkel P, Axe JL, Davidson AJ, Barut B, Noriega L, Sheng X, Zhou Y, Zon LI. The chianti zebrafish mutant provides a model for erythroid-specific disruption of transferrin receptor 1. Development. 2004 Dec; 131(24):6225-35.
-
Fraenkel, P.G., Traver, D., Donovan, A., and Zon, L.I. Ferroportin-deficienct zebrafish treated with iron dextran develop anemia despite adequate iron stores. 6th International Conference on Zebrafish Development and Genetics. 2004.
-
Fraenkel, P.G. and Zon, L.I. Zebrafish: As a model for human diseases. Nature Encyclopedia of the Human Genome, ed. David Cooper. 2003; 5:819-822.
-
Fraenkel PG, Rutkove SB, Matheson JK, Fowkes M, Cannon ME, Patti ME, Atkins MB, Gollob JA. Induction of myasthenia gravis, myositis, and insulin-dependent diabetes mellitus by high-dose interleukin-2 in a patient with renal cell cancer. J Immunother. 2002 Jul-Aug; 25(4):373-8.
-
Petrogiannis-Haliotis, T., Cannon, M.E., Fraenkel, P., Gollob, J.A., Uhl, L., Kruskall, M.S. . Myasthenia gravis and inflammatory polymyositis responsive to plasmapheresis following high dose Interleukin-2 treatment for metastatic renal cell carcinoma. Transfusion. 2000; 40(Supplement):40S.
-
Su X, Fraenkel PG, Bogorad L. Excitation energy transfer from phycocyanin to chlorophyll in an apcA-defective mutant of Synechocystis sp. PCC 6803. J Biol Chem. 1992 Nov 15; 267(32):22944-50.
-
Goodman, M.J., LaCroix, S., Goodman, P.T. . Cancer prevention and control research in Native Hawaiians: Technical report submitted under contract to the Special Populations Division, Cancer Control Program, National Cancer Institute. 1992.
This graph shows the total number of publications by year.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
|
Fraenkel's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|